SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001507496-24-000004
Filing Date
2024-04-08
Accepted
2024-04-08 21:53:12
Documents
3
Period of Report
2024-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1712627582.html 3  
1 FORM 3 wk-form3_1712627582.xml 3 3171
2 EX-24 ani-powerofattorneyforse.htm EX-24 4483
3 ani-powerofattorneyforse001.jpg GRAPHIC 279325
  Complete submission text file 0001507496-24-000004.txt   394132
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VENTRUS BIOSCIENCES, INC. 787 7TH AVENUE, 48TH FLOOR NEW YORK NY 10019
Business Address
Rowland Thomas Andrew (Reporting) CIK: 0001507496 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31812 | Film No.: 24831022